1

Accelerate Diagnostics

#10511

Rank

$859.92K

Marketcap

US United States

Country

Accelerate Diagnostics
Leadership team

Mr. Jack Phillips (CEO, Pres & Director)

Mr. Steve Reichling (Chief Financial Officer)

Mr. Ron Price (Chief Commercial Officer of Americas)

Products/ Services
Consulting, Health Care, Health Diagnostics, Hospital, Information Technology
Number of Employees
100 - 500
Headquarters
Tucson, Arizona, United States
Established
2004
Company Registration
SEC CIK number: 0000727207
Revenue
5M - 20M
Traded as
AXDX
Social Media
Overview
Location
Summary
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
History

Accelerate Diagnostics was founded in Tucson, Arizona in 2006. It was listed on the NASDAQ Global Market in April of 2015 under the symbol AXDX. The company provides healthcare providers and patients with a comprehensive picture of the patient’s systemic fungal infection.

Mission
Accelerate Diagnostics is committed to providing healthcare providers and patients with the timely results needed for the best possible outcomes.
Vision
We envision a world where healthcare providers have the information needed to give patients the best treatment for their individual needs.
Key Team

Dr. Lawrence Mertz (Chief Technology Officer)

Laura Pierson (Investor Relations Officer)

Mr. Michael Bridge (Sr. VP, Gen. Counsel & Sec.)

Mr. Cherif Bousselham (Sr. VP & Head of Sales - EMEA)

Ms. Gretchen Strohminger (Sr. VP and Head of HR & Culture)

Ms. Laura Costa (Sr. VP & Head of Global Customer Support)

Mr. John Meduri (Chief Strategy Officer)

Recognition and Awards
Accelerate Diagnostics has been awarded the Frost & Sullivan Global Company of the Year in Molecular Diagnostics, the Pressure Ulcer Prevention Provider of the Year, and has been named among the Top 50 Game Changing Companies in Healthcare.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Accelerate Diagnostics
Leadership team

Mr. Jack Phillips (CEO, Pres & Director)

Mr. Steve Reichling (Chief Financial Officer)

Mr. Ron Price (Chief Commercial Officer of Americas)

Products/ Services
Consulting, Health Care, Health Diagnostics, Hospital, Information Technology
Number of Employees
100 - 500
Headquarters
Tucson, Arizona, United States
Established
2004
Company Registration
SEC CIK number: 0000727207
Revenue
5M - 20M
Traded as
AXDX
Social Media